Who are Procalamine's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Nutrestore, Sinemet Cr, Inbrija, L-Histidine, L-acetyl carnitine, L Carnitine ( low dose).

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/lysine-acetate.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-15 · How we verify

Procalamine — Competitive Intelligence Brief

Procalamine (lysine acetate) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Amino Acid [EPC]. Area: Other.

marketed Amino Acid [EPC] Other Live · refreshed every 30 min

Target snapshot

Procalamine (lysine acetate).

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Procalamine TARGET	lysine acetate		marketed	Amino Acid [EPC]
Nutrestore	GLUTAMINE	Emmaus Medcl	marketed	Amino Acid [EPC]		2004-01-01
Sinemet Cr	CARBIDOPA	Aton	marketed	Aromatic Amino Acid [EPC]	Lysine-specific demethylase 4E	1975-01-01
Inbrija	LEVODOPA	Merz	marketed	Aromatic Amino Acid [EPC]	Tyrosine-protein kinase Fyn	1970-01-01
L-Histidine	HISTIDINE		marketed	Amino Acid [EPC]	Large neutral amino acids transporter small subunit 1
L-acetyl carnitine	L-acetyl carnitine	University of Campania Luigi Vanvitelli	marketed	Amino acid derivative / Metabolic agent	Carnitine palmitoyltransferase (CPT) system
L Carnitine ( low dose)	L Carnitine ( low dose)	Ain Shams University	marketed	Amino acid supplement / Metabolic agent	Carnitine palmitoyltransferase (CPT) system

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

2029-02-03 — Inbrija · RE43711 · Method of Use · US
2032-11-16 — Inbrija · 8685442 · Formulation · US
2032-11-16 — Inbrija · 8945612 · Formulation · US
2032-11-16 — Inbrija · 8545878 · Formulation · US
2032-11-16 — Inbrija · 9393210 · Formulation · US
2033-10-21 — Inbrija · 12458615 · Method of Use · US

Sponsor landscape (Amino Acid [EPC] class)

· 6 drugs in this class
Emmaus Medcl · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Procalamine — Competitive Intelligence Brief. https://druglandscape.com/ci/lysine-acetate. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab